Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP646006.RAXUzc20f44-hD7unuPAGmh8MTXwadPH3V_IOlMbKpnss130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP646006.RAXUzc20f44-hD7unuPAGmh8MTXwadPH3V_IOlMbKpnss130_assertion type Assertion NP646006.RAXUzc20f44-hD7unuPAGmh8MTXwadPH3V_IOlMbKpnss130_head.
- NP646006.RAXUzc20f44-hD7unuPAGmh8MTXwadPH3V_IOlMbKpnss130_assertion description "[The data suggest that p53 has opposing effects in gliomas treated with methylating or chloroethylating agents and, therefore, the p53 status should be taken into account when deciding which therapeutic drug to use.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP646006.RAXUzc20f44-hD7unuPAGmh8MTXwadPH3V_IOlMbKpnss130_provenance.
- NP646006.RAXUzc20f44-hD7unuPAGmh8MTXwadPH3V_IOlMbKpnss130_assertion evidence source_evidence_literature NP646006.RAXUzc20f44-hD7unuPAGmh8MTXwadPH3V_IOlMbKpnss130_provenance.
- NP646006.RAXUzc20f44-hD7unuPAGmh8MTXwadPH3V_IOlMbKpnss130_assertion SIO_000772 18089819 NP646006.RAXUzc20f44-hD7unuPAGmh8MTXwadPH3V_IOlMbKpnss130_provenance.
- NP646006.RAXUzc20f44-hD7unuPAGmh8MTXwadPH3V_IOlMbKpnss130_assertion wasDerivedFrom befree-2016 NP646006.RAXUzc20f44-hD7unuPAGmh8MTXwadPH3V_IOlMbKpnss130_provenance.
- NP646006.RAXUzc20f44-hD7unuPAGmh8MTXwadPH3V_IOlMbKpnss130_assertion wasGeneratedBy ECO_0000203 NP646006.RAXUzc20f44-hD7unuPAGmh8MTXwadPH3V_IOlMbKpnss130_provenance.